Health Minister Mike Nesbitt has set out a £215 million Implementation and Funding Plan aimed at shrinking Northern Ireland’s hospital waiting lists. The plan, published today, outlines a mix of “mega clinics”, additional specialist staff and a new reimbursement scheme for patients who travel outside the region for treatment.
With some patients currently waiting more than four years for routine operations, the initiative is likely to be closely watched by those waiting for care, clinicians coping with backlogs and policymakers concerned about spiralling health costs.
Funding Commitments at a Glance
- £85 million for red-flag and other time-critical cases.
- £80 million to expand long-term capacity and close the demand–supply gap.
- Up to £50 million to begin clearing the historic backlog.
In the Minister’s words, “The initiatives set out in the Implementation and Funding Plan will make a real difference to thousands of patients who have been waiting too long for assessment and treatment.”
High-Volume “Mega Clinics” and Procedure Targets
The Department of Health (DoH) intends to run “mega clinics” for around 20,000 extra patients across ophthalmology, orthopaedics, general surgery and ENT. Separately, it aims to eliminate four-year waits for approximately 3,100 patients needing hip or knee replacements, gallbladder removal (lap cholecystectomy), tonsillectomies, hernia repairs and colonoscopies.
Specialist Services Expansion
- Endoscopy: 4,743 additional sessions by March 2026, with an annual target of 16,703 extra procedures thereafter.
- Urology: three extra clinical nurse specialists and two additional inpatient theatre lists per Trust, creating capacity for 2,000 extra procedures a year.
- Rapid Diagnosis Centres: extended at South Tyrone and Whiteabbey Hospitals, focusing on quicker pancreatic cancer diagnosis for 500–600 suspected cases.
- Ophthalmology: more outpatient and surgical capacity across vitreo-retinal, corneal, macular and glaucoma sub-specialties.
- Complex Procedures: funding to reduce waits for around 300 patients requiring gynae-mesh removal, paediatric scopes, paediatric squint corrections, PEG tubes, cleft-lip repairs and scoliosis surgery.
Reimbursement Scheme Starts 2 June
From Monday, eligible patients who pay for treatment outside Northern Ireland will be able to reclaim costs under the Waiting List Reimbursement Scheme. Details on eligibility thresholds and reimbursement caps have yet to be released.
Where the Plan Leaves Questions
Workforce capacity: The document references new nursing posts and extra sessions, yet does not specify how many surgeons, anaesthetists or support staff will be recruited or seconded—critical for sustaining the additional lists.
Beyond 2025: Funding is ring-fenced for this financial year only. It would be helpful to know whether recurrent funding streams have been identified to maintain progress once the initial £215 million is spent.
Regional equity: While mega clinics promise high throughput, the announcement does not clarify how rural patients—particularly those west of the Bann—will access services concentrated in larger urban sites.
Independent sector reliance: The Minister says the urology expansion will “reduce reliance on the independent sector”, but the plan does not quantify current outsourcing levels or set reduction targets.
The full Implementation and Funding Plan is available to download on the Department’s website: Elective Care Framework – Restart, Recovery and Redesign.
Broader Context and Missing Links
Waiting lists in Northern Ireland remain the longest in the UK. As of March 2025, more than 128,000 people had been waiting over a year for an outpatient appointment. Although the new plan tackles elective procedures, it does not address related pressures in diagnostics such as MRI and CT imaging, nor the growing demand in mental-health services, which often intersect with physical-health delays.
Similarly, the press release is silent on the impact of ongoing industrial action and vacancy rates across key professions, both of which could slow planned roll-outs. Comparable initiatives in other UK nations have shown that extra clinics alone do not permanently reduce waiting times unless coupled with longer-term workforce and prevention strategies.
Questions for Further Reflection
- How will the Department ensure sufficient theatre staff and anaesthetists are available to run the promised mega clinics without affecting emergency care?
- What metrics will be published to demonstrate progress, and how frequently will performance data be released?
- Will the reimbursement scheme cover travel and accommodation costs for lower-income patients, or only clinical fees?
- How does this plan align with wider health-service reforms aimed at shifting care closer to home and reducing hospital attendances overall?
- Given the continuing GP and community-care pressures, what parallel measures are being taken to prevent future backlogs?
Looking Ahead
Today’s funding boost marks a significant attempt to reverse years of escalating waiting lists, offering tangible relief for thousands of people in immediate need of treatment. Stakeholders will now watch for detailed staffing plans, publication of performance milestones and clarity on funding beyond the current financial year—elements that will ultimately determine whether shorter waits become the norm rather than the exception.